FDA Indicates Optimism Prevnar 13 Will Show Clinical Benefit In Confirmatory Trial
This article was originally published in The Pink Sheet Daily
Executive Summary
Advisory committee votes 14-1 in favor of effectiveness and safety in adults 50 and older.